Skip Navigation



Carcinogenesis Advance Access published online on January 16, 2004

Carcinogenesis, doi:10.1093/carcin/bgh034
© 2004 by Oxford University Press
This Article
Right arrow Advance Access manuscript (PDF) Freely available
Right arrow All Versions of this Article:
25/4/549    most recent
bgh034v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Osakabe, N.
Right arrow Articles by Yoshikawa, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Osakabe, N.
Right arrow Articles by Yoshikawa, T.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2004 Oxford University Press

MOLECULAR EPIDEMIOLOGY AND CANCER PREVENTION

Rosmarinic acid inhibits epidermal inflammatory responses: anti-carcinogenic effect of Perilla frutescens extract in the murine two-stage skin model

Naomi Osakabe 1*, Akiko Yasuda 1, Midori Natsume 1, and Toshikazu Yoshikawa 2

1 Health and Bioscience Laboratories, Meiji Seika Kaisha Ltd., 5-3-1, Chiyoda Sakado 350-0289, Japan
2 First Department of Medicine, Kyoto Prefectural University of Medicine, Kamigyoku, Kyoto 602-8566 Japan

* Corresponding author. E-mail: naomi_osakabe{at}meiji.co.jp.

Received 25 June 2003 ; revised 26 October 2003 ; accepted 13 November 2003

Abstract

Perilla frutescens extract showed marked reduction on tumorigenesis in a murine, two-stage skin carcinogenesis model. In this model, cancer is initiated by application of 7, 12-dimethylbenz[a]anthracene (DMBA) and promoted by application of 12-tetradecanoylphorbol 13-acetate (TPA). Following tumor initiation with DMBA, topical application of a perilla-derived fraction(PF) at doses of 2 mg/mouse/application resulted in significant inhibition of tumorigenesis. The efficacy of each fraction was correlated with rosmarinic acid (RA) and luteolin concentration. Topical application of perilla extract (PE) that contained 68% RA or an equivalent amount of commercially available RA and luteolin showed nearly identical anti-inflammatory activity 5 hours after TPA treatment. Application of luteolin had less anti-inflammatory activity. Marked neutrophil infiltration was observed in TPA-challenged skin by histological examination using hematoxylin-eosin. This change was greatly reduced by pretreatment with PE or RA. Myeloperoxidase activity, a marker of neutrophil recruitment, was also increased in TPA-challenged skin and was significantly decreased in the PE and RA treated groups. ICAM-1 and VCAM-1 mRNA expression levels were reduced by pre-treatment with PE or RA. TPA-induced increases in synthesis of the chemokines KC and MIP-2 were significantly decreased by pre-treatment with PE or RA. Prostaglandin E2 (PGE2) and leukotriene B4 (LTB4) levels were slightly increased 5 hours after TPA treatment. These levels were only numerically decreased in the PE and RA treated groups. However, induction of cyclooxygenase-2 (COX-2) mRNA expression was obviously reduced by pretreatment with PE or RA. Reactive oxygen radical production, detected as thiobarbituric acid reactive substance (TBARS) and lipid peroxide (LPO), by double treatment of TPA was reduced by pretreatment with PE or RA. Production of 8-hydroxy-2'deoxyguanosine (8OH-dG), which was detected immunohistochemically, was also induced by double treatment with TPA. This adduct was barely visible in PE or RA treated mice. Thus, we conclude that part of the anti-carcinogenic effects of Perilla flutescens extract is due to RA via two independent mechanisms: inhibition of the inflammatory response and scavenging of reactive oxygen radicals.

rosmarinic acid, two-stage skin tumor, adhesion molecule, chemokine, ROS
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
CarcinogenesisHome page
W. Y. Chung, J. H. Park, M. J. Kim, H. O. Kim, J. K. Hwang, S. K. Lee, and K. K. Park
Xanthorrhizol inhibits 12-O-tetradecanoylphorbol-13-acetate-induced acute inflammation and two-stage mouse skin carcinogenesis by blocking the expression of ornithine decarboxylase, cyclooxygenase-2 and inducible nitric oxide synthase through mitogen-activated protein kinases and/or the nuclear factor-{kappa}B
Carcinogenesis, June 1, 2007; 28(6): 1224 - 1231.
[Abstract] [Full Text] [PDF]


Home page
Evid Based Complement Alternat MedHome page
L. A. Nakhai, A. Mohammadirad, N. Yasa, B. Minaie, S. Nikfar, G. Ghazanfari, M. J. Zamani, G. Dehghan, H. Jamshidi, V. S. Boushehri, et al.
Benefits of Zataria multiflora Boiss in Experimental Model of Mouse Inflammatory Bowel Disease
Evid. Based Complement. Altern. Med., March 1, 2007; 4(1): 43 - 50.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.